FindTrial
Sign In

A study to check the safety and effectiveness of product on human volunteers

To evaluate the safety and efficacy of skin care formulations in terms of reduction in acne (live or occurring), sebum, redness, and improvement in skin hydration and skin water barrier function on healthy human subjects - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110812
Enrollment
30
Registered
2026-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Acne Moisturiser: Product is applied on right half face two times in a day, morning and night for the period of 7 days. Intervention2: Serum + Acne Moisturiser: Product is applied on le

Sponsors

SLJ Solution Logistics LLP
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Indian female subjects. 2.Healthy subjects 3.Skin is healthy on the studied anatomic unit 4.Having mild to moderate acne. (on both the half face) 5.Having oily to mixed oily skin type.

Exclusion criteria

Exclusion criteria: 1 For female:- Being pregnant or breastfeeding or having stopped to breastfeed in the past three months 2 Having refused to give her assent by not signing the consent form 3 Taking part in another study liable to interfere with this study 4 Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months) 5 Having a progressive asthma (either under treatment or last fit in the last 2 years) 6 Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis) 7 Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) 8 Being epileptic. 9 Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, antihistamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol) 10 Having cutaneous hypersensitivity. 11 Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products. 12 Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.

Design outcomes

Primary

MeasureTime frame
Reduction in acne (live/occurring), sebum, redness, & improvement in skin hydration & skin water barrier functionTimepoint: Baseline, Day 1, day 3 and Day 7—

Secondary

MeasureTime frame
NilTimepoint: NA—

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

niharika@mascotspincontrol.in8657063276

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026